Biophausia AB
Stockholm
About Biophausia AB
BioPhausia is a Swedish specialty pharma company. BioPhausia focuses on marketing and sales of own products, licensed products and parallel-imported products. The portfolio includes strong brands such as Novalucol, Citodon and Mollipect.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Website: biophausia.se
- Phone: (468)407-6430
Social Profiles
Canonical: https://fsome.com/organization/biophausia-ab-1097260 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.